CRIS Current Research Information System

NALDI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.562
AS - Asia 7.158
EU - Europa 5.502
Continente sconosciuto - Info sul continente non disponibili 457
AF - Africa 430
SA - Sud America 384
OC - Oceania 19
Totale 22.512
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.366
SG - Singapore 1.955
CN - Cina 1.772
VN - Vietnam 1.760
IT - Italia 1.320
GB - Regno Unito 1.127
DE - Germania 654
SE - Svezia 542
HK - Hong Kong 483
IN - India 392
FR - Francia 371
RU - Federazione Russa 270
UA - Ucraina 259
BR - Brasile 248
IE - Irlanda 180
KR - Corea 155
NL - Olanda 144
CI - Costa d'Avorio 128
ZA - Sudafrica 117
JP - Giappone 115
FI - Finlandia 110
CA - Canada 108
BD - Bangladesh 95
EE - Estonia 81
CH - Svizzera 78
SC - Seychelles 65
TG - Togo 63
BG - Bulgaria 62
ES - Italia 55
AR - Argentina 52
TR - Turchia 52
ID - Indonesia 50
PH - Filippine 50
MX - Messico 43
PL - Polonia 40
TH - Thailandia 40
BE - Belgio 38
IR - Iran 38
JO - Giordania 36
PK - Pakistan 33
AT - Austria 32
GR - Grecia 30
EC - Ecuador 28
TW - Taiwan 28
IQ - Iraq 25
SA - Arabia Saudita 20
CO - Colombia 17
PT - Portogallo 17
CZ - Repubblica Ceca 16
MY - Malesia 15
CL - Cile 14
HR - Croazia 14
NG - Nigeria 13
DK - Danimarca 12
RO - Romania 12
AU - Australia 11
JM - Giamaica 10
CR - Costa Rica 9
TN - Tunisia 9
UZ - Uzbekistan 9
HN - Honduras 8
MA - Marocco 8
PY - Paraguay 8
SI - Slovenia 8
VE - Venezuela 8
DZ - Algeria 7
NP - Nepal 7
EU - Europa 6
NZ - Nuova Zelanda 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
LT - Lituania 5
OM - Oman 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
IL - Israele 4
KZ - Kazakistan 4
LB - Libano 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
ET - Etiopia 3
HU - Ungheria 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AZ - Azerbaigian 2
CM - Camerun 2
DO - Repubblica Dominicana 2
GI - Gibilterra 2
GT - Guatemala 2
KE - Kenya 2
MK - Macedonia 2
NC - Nuova Caledonia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
SM - San Marino 2
SN - Senegal 2
UG - Uganda 2
Totale 22.046
Salva come PNG Salva come JPEG
Città #
Singapore 1.408
Ashburn 1.231
Southend 948
Chandler 610
San Jose 525
Fairfield 468
Hong Kong 458
Santa Clara 378
Dong Ket 374
Bologna 370
Ho Chi Minh City 349
Hanoi 285
Council Bluffs 267
Houston 256
Wilmington 255
Princeton 230
Woodbridge 226
Hefei 218
Beijing 206
Seattle 193
Cambridge 181
Dublin 180
Jacksonville 173
Ann Arbor 171
Boardman 168
Dallas 148
Abidjan 128
Los Angeles 115
Seoul 106
Lauterbourg 104
Milan 100
Westminster 99
New York 98
Tokyo 95
Berlin 90
Nanjing 86
Helsinki 84
Padova 79
Jinan 63
Lomé 63
Chicago 62
Shenyang 62
Sofia 61
Buffalo 60
Medford 58
Bern 57
Guangzhou 57
Turin 56
Munich 49
Da Nang 47
Hebei 46
Changsha 45
Shanghai 45
Haiphong 44
Saint Petersburg 44
San Diego 44
Redmond 42
Redondo Beach 41
Falls Church 40
São Paulo 40
Frankfurt am Main 38
Rome 38
Tianjin 37
Amman 36
Phoenix 36
Redwood City 36
Des Moines 34
Brussels 33
Bengaluru 32
Jakarta 29
Mülheim 29
Paris 29
London 28
Nanchang 28
Bremen 25
Dearborn 25
Denver 25
Johannesburg 25
Hangzhou 24
Montreal 24
Orem 23
Toronto 23
Jiaxing 22
Rimini 22
San Francisco 22
Yubileyny 22
Amsterdam 21
Atlanta 21
Zhengzhou 21
Chennai 20
Nuremberg 20
Ottawa 20
Brooklyn 19
Falkenstein 19
Lappeenranta 19
The Dalles 19
Istanbul 17
Vienna 17
Barcelona 16
Hyderabad 16
Totale 13.596
Salva come PNG Salva come JPEG
Nome #
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 548
STABILITY OF ASCORBIC ACID IN COSMETIC FORMULATION: PROTECTIVE ROLE OF RESVERATROL AND MELATONIN 463
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 352
Advanced analytical methodologies in Alzheimer's disease drug discovery 304
Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease 288
New insights into the altered binding capacity of pharmaceutical-grade human serum albumin: site-specific binding studies by induced circular dichroism spectroscopy 266
Climate change effects on bread wheat phenology and grain quality: A case study in the north of Italy 264
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo 259
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 258
Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes 252
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 251
Antitumoral Efficacy of Two Turmeric Extracts According to Different Extraction Methods in Hepatocellular Carcinoma Cell Lines 250
Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth 243
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 242
Antioxidant and cytoprotective effects of a wheat-derived non specific lipid transfer protein 2 (nsLTP2) on vascular endothelial cells 237
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 235
Structural basis for the magnesium-dependent activation of transketolase from Chlamydomonas reinhardtii 234
ANTIPROLIFERATIVE ACTIVITY OF ENANTIOMERICALLY PURE (R) AND (S)-9-HYDROXYSTEARIC ACID IN HT29 COLON CANCER CELLS. 226
Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms 225
9-Hydroxystearic acid and sulforaphane: two natural HDAC inhibitors with distinct effects on HT29 cells. 224
Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer’s disease 223
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3 222
Redox-sensitive structural features of transketolase from Chlamydomonas reinhardtii (CrTK) 221
Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018 212
In vitro thrombogenicity of drug-eluting and bare metal stents 211
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties 207
Isolation and Characterization of Wheat Derived Nonspecific Lipid Transfer Protein 2 (nsLTP2) 204
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 203
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 203
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 202
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 201
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 199
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 199
AFM study of F-actin on chemically modified surfaces 193
ON-LINE GLYCAN RELEASE AND ANALYSIS BY AN INTEGRATED PNGASE F-IMER LC-ESI-Q-TOF APPROACH 193
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance 191
Unveiling the Biochemistry of the Epigenetic Regulator SMYD3 191
Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase 190
From combinations to single-molecule polypharmacology—cromolyn-ibuprofen conjugates for alzheimer’s disease 190
Inhibition of β-Amyloid Aggregation in Alzheimer's Disease: The Key Role of (Pro)electrophilic Warheads 189
CE Analysis of Basic Proteins and H4 Human Histones using a Pullulan-Coated Capillary 187
HS-SPME-GC-MS for the quantitation and chiral characterization of camphor and menthol in creams 185
Cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 182
New Coumarin derivatives as cholinergic and cannabinoid system modulators 181
Investigating in vitro amyloid peptide 1−42 aggregation: Impact of higher molecular weight stable adducts 180
ALZHEIMER'S DISEASE DRUG DISCOVERY: NEW ANALYTICAL APPROACHES FOR LEAD SELECTION AND OPTIMIZATION PBA 2009 (20h International Symposium on Pharmaceutical and Biomedical Analysis), Agra, India 01-04 Marzo 2009 179
HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy–an in vitro exploration 178
AFM study of F-actin on chemically modified surfaces 178
GA‐RAGE – Effetti dell’albumina glicata plasmatica sulla stimolazione di RAGE nel diabete mellito di tipo 2 con complicanze renali 178
A MULTI-METHODOLOGICAL APPROACH FOR BETA-AMYLOID AGGREGATION AND INHIBITION STUDIES 177
Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress 177
Acetylcholinesterase oriented immobilization on nanopatterned bilayered surfaces for biosensing devices 176
Amyloid beta-Peptide 25-35 Self Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment 176
Immobilized enzyme-based analytical tools in the -omics era: recent advances 176
HEADSPACE SOLID-PHASE MICROEXTRACTION GAS CHROMATOGRAPHY-MASS SPECTROMETRY (HS SPME-GC-MS) DETERMINATION OF ODORANTS IN GREEN TEA 174
Role of D(-)-Lactic Acid in Prevention of Chlamydia trachomatis Infection in an In Vitro Model of HeLa Cells 172
Rapid MALDI-TOF-MS analysis in the study of interaction between whole bacterial cells and human target molecules: binding of Bifidobacterium to human plasminogen 168
BIOLOGICAL EFFECTS OF A NEW CLASS I HDAC SELECTIVE INHIBITOR IN HT29 COLON CANCER CELLS. 168
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 167
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects 167
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDAC1 INHIBITION BY 9-HSA 166
Structural characterization of p53 isoforms due to the polymorphism at codon 72 by Mass Spectrometry and Circular Dichroism. 164
IMMOBILIZED ENZYMES AS TOOLS IN DRUG DISCOVERY 163
Development and characterization of beta-secretase monolithic micro-immobilized enzyme reactor for on-line high-performance liquid chromatography studies 161
Analytical approaches in Alzheimer’s disease Drug Discovery 161
A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017 160
AMYLOID-b-PEPTIDE SELF ASSEMBLY KINETICS BY AFM AND MALDI-TOF MASS SPECTROMETRY 159
Headspace solid-phase microextraction gas chromatography-mass spectrometry (HS SPME-GC-MS) determination of odorants in green tea 159
Towards automation in protein digestion: Development of a monolithic trypsin immobilized reactor for highly efficient on-line digestion and analysis 159
Fluorescence biosensing micropatterned surfaces based on immobilized human acetylcholinesterase 158
EPITOPE IDENTIFICATION OF GLYCATED HSA AND THE EXTRACELLULAR REGION OF HUMAN RAGE BY SPR AND AFFINITY-MS SPECTROMETRY 158
UHPLC determination of catechins for the quality control of green tea 154
Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry 153
Polycyclic Maleimide-based Scaffold as New Privileged Structure for Navigating the Cannabinoid System Opportunities 152
HISTONE POST-TRANSLATIONAL MODIFICATIONS BY HPLC-ESI-MS AFTER HT29 CELL TREATMENT WITH HDACS INHIBITORS. 151
Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors 151
The cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 151
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDACs INHIBITION BY SUBEROYLANILIDE HYDROXAMIC ACID. 150
The role of Chromatography in Alzheimer’s Disease Drug Discovery. 150
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors 150
Interaction between commercial glycated HSA and the extracellular region of human RAGE: a SPR-based study 149
HPLC determination of β-secretase activity on monolithic CIM disks 148
ANALYTICAL STRATEGIES FOR THE CHARACTERIZATION OF PROTEIN AGGREGATION AND INHIBITION IN HUMAN DISEASES 148
PROTEIN GLYCOSILATION ANALYSIS BY AN INTEGRATED PNGASE-F-IMER-LC-ESI-Q-TOF APPROACH 146
A multi-methodological approach for the investigation of β-Amyloid-CORMs interaction: an LC-ESI/MS and Circular Dichroism study. 144
Application of an ESI-QTOF method for the detailed characterization of GSK-3β inhibitors 144
Evidence of class I HDACs inhibition and cell cycle block in human carcinoma cells after (R) or (S)-9- HSA treatment 142
HISTONE POST-TRANSLATIONAL MODIFICATIONS DETERMINED BY HIGH-PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY 141
Histones post-translational modifications in colon cancer cell line determined by HPLC-ESI-MS and Maldi-Tof for the characterization of deacetylase inhibitors 139
Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors. 138
Hystones’ isoforms determined by HPLC-MS 137
ACETYLCHOLINESTERASE-BASED ANALYTICAL TOOLS FOR DRUG SCREENING 137
- Application of an ESI-MS method enabling the discovery of new non-ATP competitive GSK-3beta inhibitors. 136
RAGE IN DIABETES MELLITUS: A MULTIMETHODOLOGICAL STRATEGY TO STUDY GLYCATED HSA-RAGE INTERACTION 136
Application of an ESI-MS method enabling the discovery of new non-ATP competitive GSK-3beta inhibitors. 135
null 135
Development of Beta-secretase monolithic micro-imer (immobilized enzyme reactor) for on-line HPLC studies 134
Functional characterization of multifunctional ligands targeting acetylcholinesterase and alpha 7 nicotinic acetylcholine receptor 134
Discovery and in Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease 134
Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach. 133
Totale 19.111
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.234
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.936 0 0 93 124 213 128 67 198 114 177 422 400
2022/20232.561 225 315 157 330 195 210 61 186 398 110 190 184
2023/20241.321 59 125 66 86 72 154 235 307 43 59 86 29
2024/20252.960 145 432 305 217 488 160 211 108 55 178 135 526
2025/20267.176 499 721 636 475 757 460 826 232 1.296 585 353 336
2026/20271.013 180 249 584 0 0 0 0 0 0 0 0 0
Totale 22.512